Clinical Trials
25 trialsNCT01552434 2026-05-15
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT03420963 2026-03-20
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01198119 2026-03-16
NBI-CAB
Centre Oscar Lambret
Phase 2 Terminated
NCT05316688 2026-02-25
A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery
University of Washington
Phase 1/2 Terminated
NCT05536037 2025-05-15
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
Thomas Jefferson University
Phase 1 Terminated
NCT04162873 2025-02-12
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
University of Utah
Phase 2 Terminated
NCT05153733 2024-07-24
RifRam
The Netherlands Cancer Institute
Phase NA Terminated
NCT02285543 2023-11-22
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients
Shanghai Jiao Tong University School of Medicine
Phase 2 Terminated
NCT03254927 2023-04-03
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics
Phase 2 Terminated
NCT02917629 2023-03-08
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00003777 2022-01-26
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT03578432 2019-12-02
Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy
University of Arizona
Phase EARLY_PHASE1 Terminated
NCT00004261 2018-02-22
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
University Health Network, Toronto
Phase 1 Terminated
NCT01216020 2018-01-17
CTXMAB+RT
Azienda USL 4 Prato
Phase 2 Terminated
NCT00003489 2017-11-21
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00400205 2017-11-06
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
Emory University
Phase 2 Terminated
NCT00537199 2016-05-13
OraTest in Combination With Visual Examination and Visual Examination Alone
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00623129 2016-04-19
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
Mayo Clinic
Phase NA Terminated
NCT00670397 2016-03-16
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
Roswell Park Cancer Institute
Phase 1 Terminated
NCT00272181 2015-12-23
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Sesen Bio, Inc.
Phase 2 Terminated
NCT00412776 2015-12-23
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Sesen Bio, Inc.
Phase 2/3 Terminated
NCT00934739 2015-02-25
A Study of High-Risk Oral Cavity Cancer
National Health Research Institutes, Taiwan
Phase 2/3 Terminated
NCT00530088 2014-07-04
Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat
Roswell Park Cancer Institute
Phase NA Terminated
NCT00003223 2012-07-24
SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
SWOG Cancer Research Network
Phase 2 Terminated
NCT00410865 2011-12-07
Wild Type p53 Adenovirus for Oral Premalignancies
M.D. Anderson Cancer Center
Phase 1 Terminated